Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
09/15/1999 | EP0941337A1 Synthesis and purification of hepatitis c virus-like particles |
09/15/1999 | EP0941336A2 Papilloma viruses, agents for detecting the same and for treating diseases caused by such viruses |
09/15/1999 | EP0941335A2 Streptococcus pneumoniae polynucleotides and sequences |
09/15/1999 | EP0941334A2 Protease-activatable pseudomonas exotoxin a-like proproteins |
09/15/1999 | EP0941333A1 Immunogenic detoxified mutant e. coli lt-a toxin |
09/15/1999 | EP0941332A2 Carrot antifreeze polypeptides |
09/15/1999 | EP0941331A1 Processed polypeptides with il-16 activity, processes for their production and their use |
09/15/1999 | EP0941330A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
09/15/1999 | EP0941329A1 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3) |
09/15/1999 | EP0941328A1 Human breast tumor-specific proteins |
09/15/1999 | EP0941327A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor |
09/15/1999 | EP0941326A1 Murine guanine nucleotide exchange factor (mngef) and human homologues thereof |
09/15/1999 | EP0941325A1 Human homolog of the latheo gene |
09/15/1999 | EP0941324A1 Protein targeting to glycogen |
09/15/1999 | EP0941323A1 Bone morphogenetic protein-16 (bmp-16) compositions |
09/15/1999 | EP0941322A2 Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation |
09/15/1999 | EP0941321A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists |
09/15/1999 | EP0941320A2 Human proteins having transmembrane domains and dnas encoding these proteins |
09/15/1999 | EP0941319A1 Peptides capable of inhibiting the endocytosis of the app and corresponding nucleotide sequences |
09/15/1999 | EP0941318A1 Design principle for constructing expression constructs for gene therapy |
09/15/1999 | EP0941317A1 Insulin-like growth factor 1 receptor (igf-1r) antisense oligonucleotide-treated breast cancer cells composition |
09/15/1999 | EP0941316A1 Human p2x purinoreceptor |
09/15/1999 | EP0941315A1 Immune responses using compositions containing stress proteins |
09/15/1999 | EP0941314A1 Target nucleic acid sequence amplification method |
09/15/1999 | EP0941313A1 Prostate-specific kallikrein |
09/15/1999 | EP0941311A2 Type i recombinant clostridium histolyticum collagenase and its use for isolating cells and cell aggregates |
09/15/1999 | EP0941310A1 Methods for the generation of primordial germ cells and transgenic animal species |
09/15/1999 | EP0941308A2 Multi-resistant bacteria, methods for obtaining them and their uses |
09/15/1999 | EP0941307A1 Use of flexible plastic tanks in gene theraphy |
09/15/1999 | EP0941252A1 Anti-p53 single-chain antibody fragments and their uses |
09/15/1999 | EP0941250A1 HUMAN BLUE-LIGHT PHOTORECEPTOR hCRY2 |
09/15/1999 | EP0941249A1 Novel histamine h2 receptor |
09/15/1999 | EP0941248A1 Platelet secretory transport protein |
09/15/1999 | EP0941245A1 Promoter for smooth muscle cell expression |
09/15/1999 | EP0941243A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use |
09/15/1999 | EP0941242A2 Secreted proteins and polynucleotides encoding them |
09/15/1999 | EP0941241A1 $i(BORDETELLA) STRAIN EXPRESSING THE FHA HYBRID, LIPOSOMES AND VACCINES |
09/15/1999 | EP0941240A1 New picornaviruses, vaccines and diagnostic kits |
09/15/1999 | EP0941239A1 Vertebrate homologues of unc-53 protein of c. elegans |
09/15/1999 | EP0941238A2 Mutant forms of fas ligand and uses thereof |
09/15/1999 | EP0941233A2 Antiviral peptide derivatives |
09/15/1999 | EP0941142A1 Method and device for separating particles or molecules by migration through a ferrofluid |
09/15/1999 | EP0941125A1 Methods for regulating angiogenesis |
09/15/1999 | EP0941122A2 Compositions and methods for polynucleotide delivery |
09/15/1999 | EP0851874B1 Novel variants of green fluorescent protein, gfp |
09/15/1999 | EP0832098A4 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding |
09/15/1999 | EP0776335A4 Regulatable elimination of gene expression, gene product function and engineered host cells |
09/15/1999 | EP0748383B1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences |
09/15/1999 | EP0741742A4 Zwittermicin resistance gene and biocontrol bacteria with the gene |
09/15/1999 | EP0707654B1 Bacillus thuringiensis transposon tn5401 and its use in a site-specific recombination system for bacillus thuringiensis strain development |
09/15/1999 | EP0679194B1 Method to predict active growth of bacteria adhered to a surface |
09/15/1999 | EP0596918B1 Amplification of target nucleic acids using gap filling ligase chain reaction |
09/15/1999 | EP0586657B1 Receptor for the glucagon-like-peptide-1 (glp-1) |
09/15/1999 | EP0585215B1 Mutants or variants of bacillus thuringiensis producing high yields of delta endotoxin |
09/15/1999 | EP0567470B1 Pseudomonas peptide composition and method for producing the same |
09/15/1999 | CN1228814A Cassava vein mosaic virus promoters and uses thereof |
09/15/1999 | CN1228813A Gene conferring disease resistance in plants and uses thereof |
09/15/1999 | CN1228812A Microorganism, Lactamase enzyme obtained therefrom, and their use |
09/15/1999 | CN1228811A Modulators of BRCAI activity |
09/15/1999 | CN1228784A Nucleic acid encoding GAI gene of arabidopsis thaliana |
09/15/1999 | CN1228476A Method for preparing human granulocyte macrophage colony stimulating factor and its expressing carrier and engineering bacteria |
09/15/1999 | CN1228475A Method for preparing recombination human interleukin-2 and its expressing carrier and engineering bacteria |
09/14/1999 | US5952553 Herbicide resistant rice |
09/14/1999 | US5952548 Soybean glucanases, compounds which encode therefor and related methods |
09/14/1999 | US5952547 Modified Bacillus thuringiensis genes with improved expression in plant cells, methods of production on and use |
09/14/1999 | US5952546 Delayed ripening tomato plants with T-DNA bearing a truncated ACC2 synthase gene |
09/14/1999 | US5952545 Nucleic acid molecules encoding cytochrome P450-type proteins involved in the brassinosteroid synthesis in plants |
09/14/1999 | US5952544 Fatty acid desaturase genes from plants |
09/14/1999 | US5952543 Genetically transformed pineapple plants and methods for their production |
09/14/1999 | US5952490 Oligonucleotides having a conserved G4 core sequence |
09/14/1999 | US5952489 Tissue-specific promoter |
09/14/1999 | US5952488 A nucleic acid molecule containing an androgen response element linked to a reporter gene; diagnosis and therapy for prostatic diseases and cancer |
09/14/1999 | US5952487 Nucleotide sequence for hybridization probes in cancer diagnosis |
09/14/1999 | US5952486 Materials and methods for the modification of plant lignin content |
09/14/1999 | US5952485 Procedures and materials for conferring disease resistance in plants |
09/14/1999 | US5952483 Human IκB-β |
09/14/1999 | US5952482 Production of hemoglobin having a δ-like globin |
09/14/1999 | US5952481 DNA encoding ubiquitin conjugating enzymes |
09/14/1999 | US5952480 Mammalian CDP-diacylglycerol synthase |
09/14/1999 | US5952474 Fusion glycoproteins |
09/14/1999 | US5952472 Anti-fibroblast growth factor-8 monoclonal antibody |
09/14/1999 | US5952469 Murine UCP3 polypeptides |
09/14/1999 | US5952468 Isolated nucleic acid molecules which encode TAGE molecules, and uses thereof |
09/14/1999 | US5952463 Amino acid sequence of a protein which inhibits enzymes from kex2 family; development of new medicines and pesticides |
09/14/1999 | US5952461 Process for preparing human proinsulin |
09/14/1999 | US5952311 Photosensitizing chemical means for killing tumor cells, wherein tumoricidal activity is activated by absorbing light or energy within a specific wavelength range, and energy donating chemical means for activating photosensitizer |
09/14/1999 | US5952232 Expandible microparticle intracellular delivery system |
09/14/1999 | US5952229 Antisense oligonucleotide modulation of raf gene expression |
09/14/1999 | US5952228 Isolated cytolytic T cells which are specific for complexes OF HLA- B35 molecules and the peptide PHE Pro Ser Asp Ser Trp Cys Tyr PHE, and uses thereof |
09/14/1999 | US5952225 A packaging cell containing a polynucleotide which codes a portion of a selected retrovirus having at least the envelope protein; for producing vectors resistant to complement inactivation by serum; gene therapy |
09/14/1999 | US5952223 Compositions for the diagnosis and treatment of Chediak-Higashi syndrome |
09/14/1999 | US5952221 A virion having a drug-sensitivity gene and a second gene capable of providing ancillary effects to solid tumor cells; gene therapy and antitumor agents |
09/14/1999 | US5952220 Preparing a dilute viral suspension in an aqueous solution which is then nebulised with gas pressure or ultrasound; treatment of respiratory diseases, asthma, lung cancer, cystic fibrosis |
09/14/1999 | US5952217 Recombinant yeast cell and assay using same |
09/14/1999 | US5952214 Human growth-related CDC10 homolog |
09/14/1999 | US5952212 Anticarcinogenic agents and antidiabetic agents |
09/14/1999 | US5952211 Method for producing active human alanine aminotransferase |
09/14/1999 | US5952210 A nucleic acid which codes for a glutathione-s-transferase; treatment of asthma, antiallergens, antihistamines, bronchodilator agents |
09/14/1999 | US5952208 A genetically engineered microorganism that contain heterologous nucleic acids which code for desulfurization enzymes; treatment of fossil fuel that contain organosulfur compounds; pollution control |
09/14/1999 | US5952205 Process for processing sucrose into glucose and fructose |